NextCure, Inc. (NXTC) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time NXTC price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 74.1 Overbought
Market Cap $38.0M
Volume 244.1K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-24.7M
EPS $-4.68
P/E Ratio -1.8x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Simcere Zaiming, Inc. | Insider | Sell | 30,000 | $6.16 | $184,800 | 2026 Aug 10 |
| Adar1 Capital Management, LLC | 10% Owner | Buy | 329,153 | $4.93 | $1.6M | 2026 Jul 31 |
| Adar1 Capital Management, LLC | 10% Owner | Buy | 17,608 | $4.98 | $87,713 | 2026 Jul 29 |
| Powell Michael | 10% Owner | Buy | 150,000 | $36.75 | $5.5M | 2019 Nov 15 |
| Healy James | 10% Owner | Buy | 400,000 | $15.00 | $6.0M | 2019 May 13 |
| Xu Stella | Director | Buy | 125,000 | $15.00 | $1.9M | 2019 May 13 |
| Canaan Partners X LLC | 10% Owner | Buy | 50,000 | $15.00 | $750,000 | 2019 May 13 |
| Khuong Chau Quang | Director | Buy | 350,000 | $15.00 | $5.3M | 2019 May 13 |
| Shannon Timothy M | Director | Buy | 50,000 | $15.00 | $750,000 | 2019 May 13 |
| Orbimed Advisors LLC | Director | Buy | 350,000 | $15.00 | $5.3M | 2019 May 13 |
Take NXTC further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put NXTC in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when NextCure, Inc. next reports.
Set alerts on NXTC
Get notified when NextCure, Inc. hits your price targets or technical conditions are met.
Get Started Free